eVTOL Stock Face-Off: Is Joby Aviation or Archer Aviation the Better Buy Right Now?

Joby and Archer remain pre-commercial eVTOL names facing FAA approval delays, with full U.S. approvals unlikely until late 2026 or 2027. Analysts still expect Joby revenue to rise from $53 million in 2025 to $458 million in 2028 and Archer revenue from under $1 million to $482 million, but both continue to post large net losses. The article is comparatively more bullish on Joby long term, citing stronger integration, liquidity, and valuation support versus Archer.

Analysis

The market is still pricing these names like pre-revenue science projects, but the important shift is that the re-rating trigger is no longer product promise; it is regulatory optionality. That means the first tradable move will likely occur well before true commercialization, as soon as investors believe certification milestones are de-risking into a 2026-27 launch window. In that regime, the stock with the cleaner path to near-term narrative momentum can outperform the one with the better long-run unit economics.

Joby has the better strategic architecture, but that advantage is also more expensive to prove. Owning aircraft, operations, and booking flow creates a more defensible network effect, yet it also concentrates execution risk, capital intensity, and regulatory scrutiny into one balance sheet. Archer’s lower multiple reflects less control and more dependence on third parties, but that same structure can produce sharper upside on any OEM-style reorder cycle if fleet customers start treating eVTOLs like a procurement category rather than a platform bet.

The key second-order winner may not be either manufacturer, but the distribution layer around them. Airline partners and app intermediaries can monetize demand without absorbing certification risk, so DAL and UAL are positioned to capture early airport-transfer demand with limited capital at risk; UBER gets the cleanest embedded-demand optionality if integrations arrive. Meanwhile, STLA and BA benefit if manufacturing scale-outs accelerate, because the real bottleneck is not airframe demand but industrial throughput and supply-chain reliability.

The contrarian view is that the current selloff may be too focused on timing, not terminal value. If commercial service slips by another 12-18 months, equity holders likely get punished again; but if one approval milestone lands, these stocks can re-rate by multiple turns of 2028 sales because the market will discount a much longer runway of eventual fleet expansion. The trade is therefore less about near-term earnings and more about owning asymmetric regulatory convexity while avoiding the name with the most balance-sheet fragility.

Key Decisions for Investors

• Long JOBY vs short ACHR as a 6-12 month pair trade: pay up for the higher-quality platform model and cleaner liquidity profile, with upside if certification milestones compress the gap; stop if Archer secures a clearer fleet-customer pipeline or JOBY funding needs rise.
• Use ACHR calls or a defined-risk call spread into FAA milestone windows: lower absolute valuation gives more torque to a binary de-risking event, but keep size small because delay risk remains high through late 2026-2027.
• Overweight DAL and UAL as secondary beneficiaries of first-commercial-route approval: these can monetize airport-transfer demand without direct certification exposure; best held as a 12-24 month “shovel-and-hotel” trade versus the aircraft builders.
• Add STLA as a manufacturing-enablement proxy if you want lower beta exposure to eVTOL adoption: upside comes from tooling, supply-chain, and production scaling rather than aviation approval timing.
• Avoid outright leveraged longs in either JOBY or ACHR until a specific FAA milestone is achieved; the better entry is on post-delay washouts or right before a dated catalyst, not in the middle of an approval vacuum.